Classification is based on semantic text similarity scoring and may include approximations. “No match” means no high-confidence textual match was found — not necessarily that a section was removed.
🟢 New in Current Filing
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
🔒
🟢 New in Current Filing
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
🔒
🟢 New in Current Filing
Our review of potential strategic alternatives may not result in an executed or consummated transaction or other strategic alternative, and the process of reviewing strategic alternatives or the outcome could adversely affect our business.
🔒
🟢 New in Current Filing
Several of our product and service offerings, including our non-human primate supply, are dependent on a limited source of supply that, when interrupted, adversely affects our business.
🔒
🟢 New in Current Filing
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
🔒
🟢 New in Current Filing
Significant developments or changes in national laws or policies to protect or promote domestic interests and/or address foreign competition can have an adverse effect on our business and financial statements.
🔒
🟢 New in Current Filing
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
🔒
🟢 New in Current Filing
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
🔒
🔴 No Match in Current Filing
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
🔒
🔴 No Match in Current Filing
If we are not successful in selecting and integrating the businesses and technologies we acquire or partner with, or if we do not manage our current and future site closures and divestitures, our business may be adversely impacted.
🔒
🔴 No Match in Current Filing
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
🔒
🔴 No Match in Current Filing
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
🔒
🔴 No Match in Current Filing
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
🔒
🔴 No Match in Current Filing
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
🔒
🟡 Modified
Impairment of long-lived tangible assets and intangible assets (such as goodwill and other intangible assets) may adversely impact future results of operations.
🔒
🟡 Modified
Failure to execute our business strategy could adversely impact our growth and profitability.
🔒
🟡 Modified
We bear financial risk for contracts that may be terminated or reduced in scope, underpriced, subject to cost overruns or delays.
🔒
🟡 Modified
Our operations might be affected by the occurrence of a natural disaster or other catastrophic event.
🔒
🟡 Modified
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
🔒
🟡 Modified
New technologies may be developed, validated and increasingly used in biomedical research, which could reduce demand for some of our products and services.
🔒
🟡 Modified
The industries in which we operate are highly competitive.
🔒
🟡 Modified
Our quarterly operating results may vary, which could negatively affect the market price of our common stock.
🔒
🟡 Modified
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
🔒
🟡 Modified
If we are unable to attract, hire or retain key team members or a highly skilled global workforce with various backgrounds and experiences, it could have a negative impact on our business, financial condition or results of operations.
🔒
🟡 Modified
A reduction or delay in government funding of R&D may adversely affect our business.
🔒
🟡 Modified
Business and Operational Risks
🔒
🟡 Modified
Demand volatility and risk of credit losses from clients may adversely affect our business.
🔒
🟡 Modified
We are required to comply with stringent, complex and evolving laws, rules, regulations and standards in many jurisdictions, as well as contractual obligations, relating to data privacy and security. Any actual or perceived failure to comply with these requirements could have a material adverse effect on our business.
🔒
🟡 Modified
We may not be able to successfully develop and market new services and products.
🔒
🟡 Modified
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
🔒
🟡 Modified
Changes in government regulation or in practices relating to the pharmaceutical or biotechnology industries, including potential healthcare reform, could decrease the need for the services we provide.
🔒
🟡 Modified
If we are not successful in selecting and integrating the businesses and technologies we acquire or partner with, or if we do not manage our current and future site closures and divestitures, our business may be adversely impacted.
🔒
🟡 Modified
Contaminations in our animal populations can damage our inventory, harm our reputation for contaminant-free production, result in decreased sales and cause us to incur additional costs.
🔒
🟡 Modified
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
🔒
🟡 Modified
Our business is subject to risks relating to operating internationally, including changes in foreign currency exchange rates.
🔒
🟡 Modified
We depend on key personnel and may not be able to retain these employees, which could harm our business.
🔒
🟡 Modified
Legal and Regulatory Risk Factors
🔒
🟡 Modified
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
🔒
🟡 Modified
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
🔒
🟡 Modified
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
🔒
🟡 Modified
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
🔒